Syncona Limited (SYNC) Ordinary NPV
- Add to watchlist
- Create an alert
- This stock can be held in a
122.60p
124.00p
162.20p
188.20
122.80p
122.20p
105.00p
-34.96%
0.40p (0.33%) Previous:
0.40p
632,316
n/a
GBX
Price
-
Net Asset Value (NAV)
Performance
1 week 1W | 4.95% | 1 year 1Y | 16.91% |
---|---|---|---|
1 month 1M | 1.44% | 2 years 2Y | 25.03% |
3 months 3M | 0.81% | 3 years 3Y | 53.22% |
6 months 6M | 15.2% | 5 years 5Y | 49.36% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Trust Basics
Benchmark: | FTSE 250 TR GBP |
---|---|
Annual management charge: | n/a |
Performance fee: | No |
Ongoing charge: | 1.74% |
Dividend yield: | n/a |
Dividend frequency: | Annually |
Total assets: | £1,234m |
Gross gearing: | 0% |
Market capitalisation:Market cap.: | £803m |
Shares in issue: | 655.90 million |
Legal structure | Closed Ended Investment Company |
Domicile: | Guernsey |
ISIN | GG00B8P59C08 |
Dividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
Objective
NET ASSET VALUE (NAV)
Estimated NAV: | 188.20 |
---|---|
Latest actual NAV: | 188.20 |
Latest actual NAV date: | 31 December 2023 |
Premium/Discount: | -34.96% |
12m average Premium/Discount: | -27.59% |
NAV frequency: | Quarterly |
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
Security | Weight |
---|---|
Uk Treasury Bills | 13.50% |
Capital Pool Investment Funds | 7.46% |
Quell Therapeutics Limited | 6.11% |
Swan Bio Therapeutics Limited | 5.63% |
Autolus Therapeutics PLC ADR | 4.65% |
Anaveon Ag | 4.49% |
Milestone Payments | 3.74% |
Legacy Funds | 2.99% |
O Mass Therapeutics Limited | 2.60% |
Freeline Therapeutics Holdings PLC ADR | 2.42% |
Top 10 sectors currently unavailable.
Country | Weight |
---|---|
United Kingdom | 8.93% |
Key Dates
Launch date: | 26 October 2012 |
---|---|
Financial year end: | March |
Next AGM: | August 2024 |
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.